This page is part of our 2020 average annual return archive: it shows the CRDF stock yearly return for calendar year 2020. This metric helps investors evaluate and compare performance among different stocks, over time.
Average annual return should be reviewed alongside overall market trends, and company fundamentals like earnings and revenue. As the saying goes on Wall St., past performance from 2020 does not guarantee future similar returns.
| CRDF Stock Yearly Return 2020 Table | ||||||||||||||||||||||||||||||
CRDF average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare CRDF average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| CRDF Share Performance |
| CRDF Stock Yearly Return 2020 Chart | |||
Also see: • CRDF YTD return • CRDF average annual return 10 years | |||
| About Cardiff Oncology Inc |
| Cardiff Oncology is a clinical-stage, oncology therapeutics company, taking a medicine approach to target KRAS-mutated metastatic colorectal cancer, metastatic castrate-resistant prostate cancer and acute myeloid leukemia. Co.'s drug candidate, onvansertib, is an oral and highly-selective Polo-like Kinase 1 (PLK1) adenosine triphosphate competitive inhibitor. PLK1 is essential for regulating the cell division and maintaining genome stability in mitosis (cell division), spindle assembly, and DNA damage response. Co.'s intellectual property and proprietary technology enables it to analyze circulating tumor DNA and clinically actionable markers for predicting response to cancer therapies. The CRDF stock yearly return is shown above.
The yearly return on the CRDF stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2020 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the CRDF annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| CRDF Current Stock Quote |
Get Free SEC filing alerts for CRDF:
CRDF SEC Filing Email Alerts Service 
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
Video: Don't Forget Dividends in Average Annual Return!